Wallace Courtney 4
4 · Kezar Life Sciences, Inc. · Filed Jul 26, 2023
Insider Transaction Report
Form 4
Wallace Courtney
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2023-07-24−52,000→ 0 totalExercise: $13.87Exp: 2031-12-08→ Common Stock (52,000 underlying) - Award
Stock Option (Right to Buy)
2023-07-24+52,000→ 52,000 totalExercise: $2.28Exp: 2031-12-08→ Common Stock (52,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-07-24−26,000→ 0 totalExercise: $4.80Exp: 2032-06-15→ Common Stock (26,000 underlying) - Award
Stock Option (Right to Buy)
2023-07-24+26,000→ 26,000 totalExercise: $2.28Exp: 2032-06-15→ Common Stock (26,000 underlying)
Footnotes (3)
- [F1]One thirty-sixth (1/36th) of the shares vested or shall vest on a monthly basis following the vesting commencement date of December 9, 2021, subject to the Reporting Person continuing to provide service through each such date.
- [F2]On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged.
- [F3]Fully vested and exercisable.